International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 4 July-August 2024 Submit your research before last 3 days of August to publish your research paper in the issue of July-August.

Evaluation of Therapeutic Regimens for Theileriosis-affected Buffaloes in the Malwa Region of Madhya Pradesh, India

Author(s) J.U.Patil, R.K. Bagherwal, M.Singh, N.Rajput, R.Chaurasia, V. Agrawal
Country India
Abstract Three groups of 15 clinical cases of theileriosis in buffaloes from various villages in the Malwa region of Madhya Pradesh underwent therapeutic trials. Oxytetracycline (20 mg/kg IV, once daily) was used to treat five early and moderate cases of theileriosis in Group I. After receiving therapy, three made a full recovery, while two others did not. Buparvaquone was administered alone at 2.5 mg/kg IM as a single dose to Group II (n = 5) buffaloes with moderate to severe illnesses, and all five animals recovered completely. The hematological, biochemical, and clinical markers all returned to normal. Five patients in group III received oxytetracycline (20 mg/kg IV daily for five days) combined with buparvaquone 2.5 mg/kg intramuscularly. Out of the five patients in this group, three made a full recovery; one case's condition did not totally improve, and one case with severe anemia (6.8 g/dl) passed away. The findings of this study showed that buparvaquone medication is 100% successful in the early stages of the disease but fails to improve the clinical condition in the later stages.
Keywords buffaloes, theileriosis, oxytetracycline, buparvaquone,
Field Medical / Pharmacy
Published In Volume 5, Issue 5, September-October 2023
Published On 2023-09-24
Cite This Evaluation of Therapeutic Regimens for Theileriosis-affected Buffaloes in the Malwa Region of Madhya Pradesh, India - J.U.Patil, R.K. Bagherwal, M.Singh, N.Rajput, R.Chaurasia, V. Agrawal - IJFMR Volume 5, Issue 5, September-October 2023. DOI 10.36948/ijfmr.2023.v05i05.6372
DOI https://doi.org/10.36948/ijfmr.2023.v05i05.6372
Short DOI https://doi.org/gssfqm

Share this